Adaptimmune Therapeutics Plc (ADAP) — Free Cash Flow Generation Index
Adaptimmune Therapeutics Plc (ADAP) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of $46.63 Million represents 1% of operating cash flow ($47.39 Million). Explore ADAP capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Adaptimmune Therapeutics Plc Free Cash Flow Generation Index (2013–2021)
Historical FCF Generation Index trend for Adaptimmune Therapeutics Plc across 2 annual periods. For the full cash flow conversion analysis, see ADAP cash flow metrics.
Annual Free Cash Flow Generation for Adaptimmune Therapeutics Plc (2013–2021)
Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics Plc. Check ADAP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.18x | $1.95 Million | $10.73 Million | $8.78 Million | ▼ -81.1% |
| 2013 | 0.96x | $35.78 Million | $37.23 Million | $1.45 Million | — |